Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides

Sara Ram Pedersen; Jan Pravsgaard Christensen; Søren Buus; Michael Rasmussen; Karen Smith Korsholm; Morten Nielsen; Mogens Helweg Claesson

doi:10.1371/journal.pone.0145629

Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides

Sara Ram Pedersen, Jan Pravsgaard Christensen, Søren Buus, Michael Rasmussen, Karen Smith Korsholm, Morten Nielsen, Mogens Helweg Claesson

5 Citations (Scopus)

88 Downloads (Pure)

Abstract

The aim of the present study was to identify influenza A-derived peptides which bind to both HLA class I and -II molecules and by immunization lead to both HLA class I and class II restricted immune responses. Eight influenza A-derived 9-11mer peptides with simultaneous binding to both HLA-A*02:01 and HLA-DRB1*01:01 molecules were identified by bioinformatics and biochemical technology. Immunization of transgenic HLA-A*02:01/HLA-DRB1*01:01 mice with four of these double binding peptides gave rise to both HLA class I and class II restricted responses by CD8 and CD4 T cells, respectively, whereas four of the double binding peptides did result in HLA-A*02:01 restricted responses only. According to their cytokine profile, the CD4 T cell responses were of the Th2 type. In influenza infected mice, we were unable to detect natural processing in vivo of the double restricted peptides and in line with this, peptide vaccination did not decrease virus titres in the lungs of intranasally influenza challenged mice. Our data show that HLA class I and class II double binding peptides can be identified by bioinformatics and biochemical technology. By immunization, double binding peptides can give rise to both HLA class I and class I restricted responses, a quality which might be of potential interest for peptide-based vaccine development.

Original language	English
Article number	e0145629
Journal	P L o S One
Volume	11
Issue number	1
Number of pages	16
ISSN	1932-6203
DOIs	https://doi.org/10.1371/journal.pone.0145629
Publication status	Published - 5 Jan 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1371/journal.pone.0145629Licence: CC BY

Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived PeptidesFinal published version, 513 KBLicence: CC BY

Cite this

@article{3486b873034546048e79f1ce94bf7d95,

title = "Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides",

abstract = "The aim of the present study was to identify influenza A-derived peptides which bind to both HLA class I and -II molecules and by immunization lead to both HLA class I and class II restricted immune responses. Eight influenza A-derived 9-11mer peptides with simultaneous binding to both HLA-A*02:01 and HLA-DRB1*01:01 molecules were identified by bioinformatics and biochemical technology. Immunization of transgenic HLA-A*02:01/HLA-DRB1*01:01 mice with four of these double binding peptides gave rise to both HLA class I and class II restricted responses by CD8 and CD4 T cells, respectively, whereas four of the double binding peptides did result in HLA-A*02:01 restricted responses only. According to their cytokine profile, the CD4 T cell responses were of the Th2 type. In influenza infected mice, we were unable to detect natural processing in vivo of the double restricted peptides and in line with this, peptide vaccination did not decrease virus titres in the lungs of intranasally influenza challenged mice. Our data show that HLA class I and class II double binding peptides can be identified by bioinformatics and biochemical technology. By immunization, double binding peptides can give rise to both HLA class I and class I restricted responses, a quality which might be of potential interest for peptide-based vaccine development.",

author = "Pedersen, {Sara Ram} and Christensen, {Jan Pravsgaard} and S{\o}ren Buus and Michael Rasmussen and Korsholm, {Karen Smith} and Morten Nielsen and Claesson, {Mogens Helweg}",

year = "2016",

month = jan,

day = "5",

doi = "10.1371/journal.pone.0145629",

language = "English",

volume = "11",

journal = "PLoS Computational Biology",

issn = "1932-6203",

publisher = "Public Library of Science",

number = "1",

}

TY - JOUR

T1 - Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides

AU - Pedersen, Sara Ram

AU - Christensen, Jan Pravsgaard

AU - Buus, Søren

AU - Rasmussen, Michael

AU - Korsholm, Karen Smith

AU - Nielsen, Morten

AU - Claesson, Mogens Helweg

PY - 2016/1/5

Y1 - 2016/1/5

N2 - The aim of the present study was to identify influenza A-derived peptides which bind to both HLA class I and -II molecules and by immunization lead to both HLA class I and class II restricted immune responses. Eight influenza A-derived 9-11mer peptides with simultaneous binding to both HLA-A*02:01 and HLA-DRB1*01:01 molecules were identified by bioinformatics and biochemical technology. Immunization of transgenic HLA-A*02:01/HLA-DRB1*01:01 mice with four of these double binding peptides gave rise to both HLA class I and class II restricted responses by CD8 and CD4 T cells, respectively, whereas four of the double binding peptides did result in HLA-A*02:01 restricted responses only. According to their cytokine profile, the CD4 T cell responses were of the Th2 type. In influenza infected mice, we were unable to detect natural processing in vivo of the double restricted peptides and in line with this, peptide vaccination did not decrease virus titres in the lungs of intranasally influenza challenged mice. Our data show that HLA class I and class II double binding peptides can be identified by bioinformatics and biochemical technology. By immunization, double binding peptides can give rise to both HLA class I and class I restricted responses, a quality which might be of potential interest for peptide-based vaccine development.

AB - The aim of the present study was to identify influenza A-derived peptides which bind to both HLA class I and -II molecules and by immunization lead to both HLA class I and class II restricted immune responses. Eight influenza A-derived 9-11mer peptides with simultaneous binding to both HLA-A*02:01 and HLA-DRB1*01:01 molecules were identified by bioinformatics and biochemical technology. Immunization of transgenic HLA-A*02:01/HLA-DRB1*01:01 mice with four of these double binding peptides gave rise to both HLA class I and class II restricted responses by CD8 and CD4 T cells, respectively, whereas four of the double binding peptides did result in HLA-A*02:01 restricted responses only. According to their cytokine profile, the CD4 T cell responses were of the Th2 type. In influenza infected mice, we were unable to detect natural processing in vivo of the double restricted peptides and in line with this, peptide vaccination did not decrease virus titres in the lungs of intranasally influenza challenged mice. Our data show that HLA class I and class II double binding peptides can be identified by bioinformatics and biochemical technology. By immunization, double binding peptides can give rise to both HLA class I and class I restricted responses, a quality which might be of potential interest for peptide-based vaccine development.

U2 - 10.1371/journal.pone.0145629

DO - 10.1371/journal.pone.0145629

M3 - Journal article

C2 - 26731261

SN - 1932-6203

VL - 11

JO - PLoS Computational Biology

JF - PLoS Computational Biology

IS - 1

M1 - e0145629

ER -

Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this